Type 2 Diabetes Defeated

Quick Diabetes Cure

Get Instant Access

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993.

2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional Ueatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853, 1998.

3. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet 352:854-865, 1998.

4. Barnett AH, Owens DR. Insulin analogues. Lancet 349:47-51, 1997.

5. Holleman F, Hoekstra JB. Insulin lispro. N Engl J Med 337:176-183, 1997.

6. Bolli GB, Di Marchi RD, Park GD, Pramming S, Koivisto VA. Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia 42:11511167, 1999.

7. BoLLi GB, Owens DR. Insulin glargine. Lancet 356:443-445, 2000.

8. Polonsky KS, Given BD, Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 81:442448, 1988.

9. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 24(suppl 1):S33-S43, 2001.

10. American Diabetes Association. Postprandial blood glucose. Diabetes Care 24:775778, 2001.

11. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46:271-286, 1997.

12. Simonson DC, Tamborlane WV, DeFronzo RA, Sherwin RS. Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. Ann Intern Med 103:184-190, 1985.

13. Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS. Defective glucose counter-regulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med 316:1376-1383, 1987.

14. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993.

15. Colagiuri S, Villalobos S. Assessing effect of mixing insulins by glucose-clamp technique in subjects with diabetes mellitus. Diabetes Care 9:579-586, 1986.

16. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49:2142-2148, 2000.

17. Brunelle BL, Llewelyn J, Anderson JH Jr, Gale EA, Koivisto VA. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 21:1726-1731, 1998.

18. Heller SR, Amiel SA, Mansell P. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group. Diabetes Care 22:1607-1611, 1999.

19. Gale EA. The UK Trial Group. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type I diabetes on intensified insulin therapy. Diabet Med 17:209-214, 2000.

20. Rassam AG, Zeise TM, B├╝rge MR, Schade DS. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes. Diabetes Care 22:133-136, 1999.

21. Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 23:644-649, 2000.

22. Raskin P, Klaff L, Bergenstal R, Halle JP, Donley D, Mecca T. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care 23:16661671, 2000.

23. Rosenstock J, Park G, Zimmerman J. Basal insulin glargine (HOE 901) versus NPH

Was this article helpful?

0 0
Diabetes Sustenance

Diabetes Sustenance

Get All The Support And Guidance You Need To Be A Success At Dealing With Diabetes The Healthy Way. This Book Is One Of The Most Valuable Resources In The World When It Comes To Learning How Nutritional Supplements Can Control Sugar Levels.

Get My Free Ebook

Post a comment